Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Cancer Immunology, Immunotherapy : CII
|
June 18, 2013
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue
Anna M Sherwood, Ryan O Emerson, Dominique Scherer, et al.
Cancers
|
April 3, 2021
Predicting the Risk of Metastases by PSMA-PET/CT-Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma
Stefan A Koerber, Johannes Boesch, Clemens Kratochwil, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 2, 2021
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience
Florian Eichhorn, Laura V Klotz, Mark Kriegsmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trial
Georg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2023
Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
Stefan A Koerber, Manuel Röhrich, Leon Walkenbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2018
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y Janjigian, Johanna Bendell, Emiliano Calvo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2020
The Role of <sup>68</sup>Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience
Stefan A Koerber, Fabian Staudinger, Clemens Kratochwil, et al.
Cell Death & Disease
|
August 19, 2016
Bcl-xL is an oncogenic driver in colorectal cancer
Anna-Lena Scherr, Georg Gdynia, Mariam Salou, et al.
Cancer Research
|
August 18, 2011
Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy
Niels Halama, Sara Michel, Matthias Kloor, et al.
The Lancet. Oncology
|
October 14, 2016
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
Padmanee Sharma, Margaret K Callahan, Petri Bono, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Cancer Immunology, Immunotherapy : CII
|
June 18, 2013
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue
Anna M Sherwood, Ryan O Emerson, Dominique Scherer, et al.
Cancers
|
April 3, 2021
Predicting the Risk of Metastases by PSMA-PET/CT-Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma
Stefan A Koerber, Johannes Boesch, Clemens Kratochwil, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 2, 2021
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience
Florian Eichhorn, Laura V Klotz, Mark Kriegsmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trial
Georg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2023
Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
Stefan A Koerber, Manuel Röhrich, Leon Walkenbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2018
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y Janjigian, Johanna Bendell, Emiliano Calvo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2020
The Role of <sup>68</sup>Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience
Stefan A Koerber, Fabian Staudinger, Clemens Kratochwil, et al.
Cell Death & Disease
|
August 19, 2016
Bcl-xL is an oncogenic driver in colorectal cancer
Anna-Lena Scherr, Georg Gdynia, Mariam Salou, et al.
Cancer Research
|
August 18, 2011
Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy
Niels Halama, Sara Michel, Matthias Kloor, et al.
The Lancet. Oncology
|
October 14, 2016
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
Padmanee Sharma, Margaret K Callahan, Petri Bono, et al.
Page
of 6